Address	151 Oyster Point Boulevard South San Francisco California 94080 United States
Employees	-
Website	http://www.cytomx.com
Updated	07/08/2019
CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs. The company was founded by Frederick W.